1. On Individual Preferences and Aggregation in Economic Evaluation in Healthcare

   • Bengt Liljas
   • Björn Lindgren

   Leading Article 23 September 2012 Pages: 323 - 335

   

2. Pharmacoeconomics of Hypertension Management

   • Ettore Ambrosioni

   Review Article 23 September 2012 Pages: 337 - 347

   

3. Symptom and Health-Related Quality-of-Life Measures for Use in Selected Gastrointestinal Disease Studies

   • Anne M. Rentz
   • Carmelina Battista
   • Dennis A. Revicki

   Review Article 23 September 2012 Pages: 349 - 363

   

4. Augmenting Reference Pricing of Pharmaceuticals in New Zealand with Strategic Cross-Product Agreements

   • Alan Woodfield

   Review Article 23 September 2012 Pages: 365 - 377

   

5. The Cost of Treatment of Alzheimer’s Disease in The Netherlands

   • Joseph McDonnell
   • W. Ken Redekop
   • Frans F. H. Rutten

   Original Research Article 23 September 2012 Pages: 379 - 390

   

6. Cost-Benefit Analysis of a Haemophilus Influenzae Type B Meningitis Prevention Programme in The Philippines

   • M. Rhona M. T. Limcangco
   • Carol L. Armour
   • Susan J. Taylor

   Original Research Article 23 September 2012 Pages: 391 - 400

   

7. Cost Effectiveness of Continuous Terbinafine Compared with Intermittent Itraconazole in the Treatment of Dermatophyte Toenail Onychomycosis

   • Ronald Jansen
   • W. Ken Redekop
   • Frans F. H. Rutten

   Original Research Article 23 September 2012 Pages: 401 - 410

   

8. Cost-Effectiveness Analysis of n-3 Polyunsaturated Fatty Acids (PUFA) after Myocardial Infarction

   • Maria Grazia Franzosi
   • Massimo Brunetti
   • Franco Valagussa

   Original Research Article 23 September 2012 Pages: 411 - 420

   

9. Efavirenz

   • Greg L. Plosker
   • Caroline M. Perry
   • Karen L. Goa

   Adis Pharmacoeconomic Drug Evaluation 23 September 2012 Pages: 421 - 436